Science Explorer Back to mapMap
Discussion

Cancer, Stress, Anesthesia, and Immune Response

Cancer, Stress, Anesthesia, and Immune Response is a research topic within Psychiatry and Mental health. Science Explorer counts 26k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the impact of chronic stress, neuroendocrine modulation, anesthetic techniques, and immune suppression on tumor growth, metastasis promotion, and angiogenesis regulation. It delves into the influence of the nervous system during the perioperative period and highlights the role of adrenergic signaling in cancer progression.

  • Chronic Stress
  • Tumor Growth
  • Neuroendocrine Modulation
  • Anesthetic Technique
  • Immune Suppression
  • Metastasis Promotion
  • Adrenergic Signaling
  • Nervous System Influence
  • Angiogenesis Regulation
  • Perioperative Period
Research works
26k
fractional, since 1950
In the world top 10%
2.6k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+21%
the tick is no change
Largest producer
China
40% of the 10 largest, 2022-now
Cancer, Stress, Anesthesia, and Immune Response

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cancer, Stress, Anesthesia, and Immune Response research?

By volume, China and the United States publish the most (1.9k and 1.4k works in 2022-now).

By volume, 2022-now

  1. 1 China 1.9k works
  2. 2 United States 1.4k works
  3. 3 India 290 works
  4. 4 Japan 267 works
  5. 5 Italy 167 works
  6. 6 Germany 167 works
  7. 7 United Kingdom 161 works
  8. 8 South Korea 158 works
  9. 9 Türkiye 141 works
  10. 10 Iran 127 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 40.3%United States: 28.6%India: 6.1%Japan: 5.6%6 others listed: 19.4%40%largest
China1,918 · 40.3%United States1,360 · 28.6%India290 · 6.1%Japan267 · 5.6%6 others listed922 · 19.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cancer, Stress, Anesthesia, and Immune Response research?

By volume in 2022-now, Sun Yat-sen University publishes the most Cancer, Stress, Anesthesia, and Immune Response research, followed by Sichuan University and Harvard University.

Who are the leading researchers in Cancer, Stress, Anesthesia, and Immune Response?

The most-cited researchers publishing on Cancer, Stress, Anesthesia, and Immune Response include David Moher, George Davey Smith and Walter Churchill Willett.

  1. 1 David Moher Canada 898k citations
  2. 2 George Davey Smith United Kingdom 435k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 Guido Kroemer France 386k citations
  5. 5 Bert Vogelstein United States 373k citations
  6. 6 Jost Bruno Jonas Germany 350k citations
  7. 7 Hermann Brenner Germany 343k citations
  8. 8 Shizuo Akira Japan 342k citations
  9. 9 Jun Wang China 340k citations
  10. 10 Gregory Y.H. Lip United Kingdom 311k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cancer, Stress, Anesthesia, and Immune Response?

The most cited paper in Cancer, Stress, Anesthesia, and Immune Response is "Immunity, Inflammation, and Cancer" (Sergei I. Grivennikov, Florian R. Greten, Michael Karin, 2010), with 10,888 citations. Next come "Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial." (5,935) and "Elements of cancer immunity and the cancer–immune set point" (5,520).

Most cited papers
#PaperReleasedCitations
1 Immunity, Inflammation, and Cancer Sergei I. Grivennikov, Florian R. Greten, Michael Karin · Cell Open access Mar 2010 10,888
2 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology Jun 1997 5,935
3 Elements of cancer immunity and the cancer–immune set point Daniel S. Chen, Ira Mellman · Nature 2017 5,520
4 Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Patricia Cortazar et al. · The Lancet Open access 13 Feb 2014 4,858
5 ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe‐Jauffret et al. · Cell stem cell Open access Nov 2007 4,039
All 100 most cited papers, with filters and sorting

Where is Cancer, Stress, Anesthesia, and Immune Response research done?

The largest centres of Cancer, Stress, Anesthesia, and Immune Response research in 2022-now are Shanghai (China), Beijing (China), Guangzhou (China) and Chengdu (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nantong.

Largest cities, 2022-now

  1. 1 ShanghaiChina 170 works
  2. 2 BeijingChina 170 works
  3. 3 GuangzhouChina 120 works
  4. 4 ChengduChina 86 works
  5. 5 SeoulSouth Korea 85 works
  6. 6 NanjingChina 83 works
  7. 7 HoustonUnited States 72 works
  8. 8 HangzhouChina 70 works
  9. 9 New YorkUnited States 70 works
  10. 10 TokyoJapan 66 works

Where it is the local speciality

  1. NantongCN · 20.3 works7.0×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cancer, Stress, Anesthesia, and Immune Response than the world average.

See Cancer, Stress, Anesthesia, and Immune Response on the map

Where is the best place to study Cancer, Stress, Anesthesia, and Immune Response?

Among universities, judged by research, Sichuan University, Sun Yat-sen University and Shanghai Jiao Tong University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 18.89%fractional works in this field (log) →share of work in the world top 10% →Duke UniversitySichuan UniversityShanghai Jiao Tong U…Sun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sichuan UniversityChina 78.321.4%4.3×53 +55.3%
2Sun Yat-sen UniversityChina 71.715.8%5.0×57 +30.3%
3Shanghai Jiao Tong UniversityChina 70.018.3%3.2×50 +10.1%
4Duke UniversityUnited States 69.721.8%3.6×16 +69.5%
5Huazhong University of Science and TechnologyChina 68.322.0%3.0×30 +31.3%
6Harvard UniversityUnited States 67.711.0%2.9×51 -11.6%
7Fudan UniversityChina 64.917.2%3.9×33 +13.7%
8Southern Medical UniversityChina 63.921.7%6.9×23 +45.5%
9Soochow UniversityChina 61.817.5%4.7×25 +52.7%
10Tongji UniversityChina 61.422.2%2.1×18 +79.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cancer, Stress, Anesthesia, and Immune Response, country by country

Is Cancer, Stress, Anesthesia, and Immune Response research growing?

Output in 2022-2025 was 21% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cancer, Stress, Anesthesia, and Immune Response.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cancer, Stress, Anesthesia, and Immune Response as a percentage of every work published that year, 0.023% in 2024.

still counting0.010%0.020%0.030%Cancer, Stress, Anesthesia, and Immune Response0.027% in 202519801990200020102020

Fractional works of Cancer, Stress, Anesthesia, and Immune Response over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cancer, Stress, Anesthesia, and Immune Response10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cancer, Stress, Anesthesia, and Immune Response. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.